Focused Wealth Management’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-200
| Closed | -$11.6K | – | 275 |
|
|
2023
Q4 | $11.6K | Hold |
200
| – | – | ﹤0.01% | 520 |
|
|
2023
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 525 |
|
|
2023
Q2 | $10.5K | Hold |
200
| – | – | ﹤0.01% | 534 |
|
|
2023
Q1 | $9.86K | Hold |
200
| – | – | ﹤0.01% | 547 |
|
|
2022
Q4 | $9.86K | Hold |
200
| – | – | ﹤0.01% | 532 |
|
|
2022
Q3 | $9K | Sell |
200
-200
| -50% | -$9.23K | ﹤0.01% | 505 |
|
|
2022
Q2 | $17K | Hold |
400
| – | – | ﹤0.01% | 427 |
|
|
2022
Q1 | $17K | Hold |
400
| – | – | ﹤0.01% | 471 |
|
|
2021
Q4 | $20K | Hold |
400
| – | – | ﹤0.01% | 487 |
|
|
2021
Q3 | $20K | Sell |
400
-300
| -43% | -$15.5K | ﹤0.01% | 505 |
|
|
2021
Q2 | $37K | Hold |
700
| – | – | 0.01% | 420 |
|
|
2021
Q1 | $37K | Hold |
700
| – | – | 0.01% | 411 |
|
|
2020
Q4 | $37K | Hold |
700
| – | – | 0.01% | 383 |
|
|
2020
Q3 | $33K | Hold |
700
| – | – | 0.01% | 364 |
|
|
2020
Q2 | $33K | Hold |
700
| – | – | 0.01% | 346 |
|
|
2020
Q1 | $26K | Hold |
700
| – | – | 0.01% | 339 |
|
|
2019
Q4 | $30K | Hold |
700
| – | – | 0.01% | 356 |
|
|
2019
Q3 | $25K | Hold |
700
| – | – | 0.01% | 359 |
|
|
2019
Q2 | $29K | Hold |
700
| – | – | 0.01% | 374 |
|
|
2019
Q1 | $31K | Hold |
700
| – | – | 0.01% | 330 |
|
|
2018
Q4 | $24K | Hold |
700
| – | – | 0.01% | 365 |
|
|
2018
Q3 | $32K | Hold |
700
| – | – | 0.01% | 331 |
|
|
2018
Q2 | $31K | Hold |
700
| – | – | 0.01% | 314 |
|
|
2018
Q1 | $29K | Sell |
700
-300
| -30% | -$12.6K | 0.01% | 344 |
|
|
2017
Q4 | $41K | Hold |
1,000
| – | – | 0.01% | 314 |
|
|
2017
Q3 | $42K | Hold |
1,000
| – | – | 0.01% | 253 |
|
|
2017
Q2 | $40K | Hold |
1,000
| – | – | 0.01% | 307 |
|
|
2017
Q1 | $38K | Hold |
1,000
| – | – | 0.01% | 310 |
|
|
2016
Q4 | $33K | Hold |
1,000
| – | – | 0.01% | 318 |
|
|
2016
Q3 | $33K | Hold |
1,000
| – | – | 0.01% | 310 |
|
|
2016
Q2 | $27K | Buy |
1,000
+300
| +43% | +$7.92K | 0.01% | 314 |
|
|
2016
Q1 | $17K | Buy |
700
+100
| +17% | +$2.43K | 0.01% | 320 |
|
|
2015
Q4 | $18K | Hold |
600
| – | – | 0.01% | 329 |
|
|
2015
Q3 | $17K | Hold |
600
| – | – | 0.01% | 317 |
|
|
2015
Q2 | $21K | Hold |
600
| – | – | 0.01% | 299 |
|
|
2015
Q1 | $19K | Buy |
+600
| New | +$17.6K | 0.01% | 325 |
|
Other funds holding BBP
RJFSA
IFG
Focused Wealth Management's BBP Position: Q1 2024 in Review
Focused Wealth Management sold out of Virtus Biotech ETF (BBP) in Q1 2024, closing a stake of 200 shares — an estimated $11.6K sold.
Focused Wealth Management first reported a position in BBP in Q1 2015 and held it in 36 quarters. The position peaked at $42K in Q3 2017. 14 funds tracked by Wall St. Rank hold BBP as of Q1 2024.
- Focused Wealth Management reported no remaining Virtus Biotech ETF position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 200 Virtus Biotech ETF shares in Q1 2024, an estimated $11.6K.
- Focused Wealth Management first reported a position in Virtus Biotech ETF in Q1 2015 and held it in 36 quarters.
- Focused Wealth Management's Virtus Biotech ETF position peaked at $42K in Q3 2017.
- 14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.